Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
The World Health Organisation chooses British air purification company, MedicAir, to tackle ‘invisible threat’ in hospitals
British air purification company, MedicAir, has beaten international firms to be awarded a year-long contract by […]
Jesduvroq Approved by US FDA for Anaemia of Chronic Kidney Disease in Adults on Dialysis
GSK today announced that the US Food and Drug Administration (FDA) has approved Jesduvroq (daprodustat), […]
Sherlock Biosciences Acquires Sense Biodetection Advancing CRISPR-Based Diagnostics for Consumers
Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point of need, […]
Genoscience Pharma receives FDA Orphan Drug Designation for ezurpimtrostat to treat HepatoCellular Carcinoma (HCC)
Genoscience Pharma, a clinical-stage biotech company developing unique lysosomotropic drug candidates for the treatment of […]
AviadoBio Announces Appointment of Jeff Goater as Chair of the Board of Directors
AviadoBio, a pioneering, pre-clinical stage gene therapy company focused on developing and delivering transformative medicines […]
Ellipses Pharma Announces FDA Approval of IND Application for EP0042 for Patients With Acute Myeloid Leukaemia
Ellipses Pharma, a global drug development company focused on accelerating the development of cancer medicines […]
Ariceum Therapeutics Appoints Radioligand Expert, Germo Gericke, as Chief Medical Officer
Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and systemic […]
NHS To Offer Licensed Cannabis-Based Medicine To Treat Rare Genetic Condition
The NHS will be able to prescribe cannabidiol (Cannabis) to patients with a rare, seizure-causing […]
Orbit Discovery and Endevica Bio Enter Multi-target Collaboration to Advance Development of Cachexia Therapeutics
Orbit Discovery, a leader in the discovery of therapeutic peptide hits, today announced it has […]
CARsgen Announces Collaboration Agreement with Roche to Evaluate AB011 in Combination with PD-L1 Checkpoint Inhibitor to Treat Gastric Cancer
CARsgen Therapeutics, a company focused on innovative therapies for the treatment of hematologic malignancies and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more